1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Raibaud, S. Lebars, I. Bontems, F. Dardel, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 323 143 10.1016/S0022-2836(02)00921-X 12368106 NMR Structure of Bacterial Ribosomal Protein L20: Implications for Ribosome Assembly and Translational Control 2002 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6754.834 50S RIBOSOMAL PROTEIN L20 RESIDUES 59-118 1 man polymer no no WIARINAAVRAYGLNYSTFINGLKKAGIELDRKILADMAVRDPQAFEQVVNKVKEALQVQ WIARINAAVRAYGLNYSTFINGLKKAGIELDRKILADMAVRDPQAFEQVVNKVKEALQVQ A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n VF5 sample 224324 AQUIFEX AEOLICUS 469008 ESCHERICHIA COLI BL21(DE3) PUBS520 PLASMID PET11C repository Initial release Version format compliance Version format compliance 1 0 2002-05-10 1 1 2011-05-08 1 2 2011-07-13 PDBE Y PDBE 2002-05-02 REL THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY ON 13C, 15N-LABELED L20. THE FIRST 58 RESIDUES ARE PRESENT IN THE SAMPLE BUT ARE DISORDERED IN SOLUTION LOWEST DIANA TARGET FUNCTION 100 20 HNCA NOESY-HMQC TOCSY-HMQC HCCH-TOCSY NOESY DQF-COSY HNHA HNHB 0.5 6.5 pH 1 atm 318 K RESTRAINED SIMUATED ANNEALING FOLLOWED BY A FINAL MINIMIZATION USING THE CHARMM22 FORCEFIELD HYBRID : DIANA FOLLOWED BY RESTRAINED SIMULATED ANNEALING 7 BRUNGER refinement X-PLOR 3.89 structure solution DIANA structure solution XPLOR 600 Bruker DRX TRP 59 n 1 TRP 59 A ILE 60 n 2 ILE 60 A ALA 61 n 3 ALA 61 A ARG 62 n 4 ARG 62 A ILE 63 n 5 ILE 63 A ASN 64 n 6 ASN 64 A ALA 65 n 7 ALA 65 A ALA 66 n 8 ALA 66 A VAL 67 n 9 VAL 67 A ARG 68 n 10 ARG 68 A ALA 69 n 11 ALA 69 A TYR 70 n 12 TYR 70 A GLY 71 n 13 GLY 71 A LEU 72 n 14 LEU 72 A ASN 73 n 15 ASN 73 A TYR 74 n 16 TYR 74 A SER 75 n 17 SER 75 A THR 76 n 18 THR 76 A PHE 77 n 19 PHE 77 A ILE 78 n 20 ILE 78 A ASN 79 n 21 ASN 79 A GLY 80 n 22 GLY 80 A LEU 81 n 23 LEU 81 A LYS 82 n 24 LYS 82 A LYS 83 n 25 LYS 83 A ALA 84 n 26 ALA 84 A GLY 85 n 27 GLY 85 A ILE 86 n 28 ILE 86 A GLU 87 n 29 GLU 87 A LEU 88 n 30 LEU 88 A ASP 89 n 31 ASP 89 A ARG 90 n 32 ARG 90 A LYS 91 n 33 LYS 91 A ILE 92 n 34 ILE 92 A LEU 93 n 35 LEU 93 A ALA 94 n 36 ALA 94 A ASP 95 n 37 ASP 95 A MET 96 n 38 MET 96 A ALA 97 n 39 ALA 97 A VAL 98 n 40 VAL 98 A ARG 99 n 41 ARG 99 A ASP 100 n 42 ASP 100 A PRO 101 n 43 PRO 101 A GLN 102 n 44 GLN 102 A ALA 103 n 45 ALA 103 A PHE 104 n 46 PHE 104 A GLU 105 n 47 GLU 105 A GLN 106 n 48 GLN 106 A VAL 107 n 49 VAL 107 A VAL 108 n 50 VAL 108 A ASN 109 n 51 ASN 109 A LYS 110 n 52 LYS 110 A VAL 111 n 53 VAL 111 A LYS 112 n 54 LYS 112 A GLU 113 n 55 GLU 113 A ALA 114 n 56 ALA 114 A LEU 115 n 57 LEU 115 A GLN 116 n 58 GLN 116 A VAL 117 n 59 VAL 117 A GLN 118 n 60 GLN 118 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 7 A A H H ASP ARG 89 90 1.14 11 A A H H ARG LYS 90 91 1.29 13 A A H3 H TRP ILE 59 60 1.22 14 A A H H VAL GLN 117 118 1.19 18 A A H H ARG LYS 90 91 1.34 1 A A LEU GLN 115 116 -144.04 5 A A LEU GLN 115 116 -145.47 7 A A LEU GLN 115 116 -144.31 9 A A VAL LYS 111 112 149.93 10 A A ASP ARG 89 90 -145.01 13 A A ASP ARG 89 90 111.56 18 A A LEU GLN 115 116 -146.91 1 -3.65 0.60 121.00 117.35 A A A CB CG CD2 TYR TYR TYR 74 74 74 N 1 3.68 0.60 121.00 124.68 A A A CB CG CD1 TYR TYR TYR 74 74 74 N 3 -4.73 0.60 121.00 116.27 A A A CB CG CD2 TYR TYR TYR 74 74 74 N 3 5.17 0.60 121.00 126.17 A A A CB CG CD1 TYR TYR TYR 74 74 74 N 3 -12.42 1.90 110.20 97.78 A A A CB CA C LEU LEU LEU 93 93 93 N 5 4.28 0.70 120.80 125.08 A A A CB CG CD1 PHE PHE PHE 77 77 77 N 9 20.25 1.90 113.70 133.95 A A A CA CB CG TRP TRP TRP 59 59 59 N 9 16.08 2.50 121.70 137.78 A A A C N CA ARG LYS LYS 90 91 91 Y 9 -11.50 1.90 110.20 98.70 A A A CB CA C LEU LEU LEU 93 93 93 N 10 -9.13 1.50 110.10 100.97 A A A CB CA C ALA ALA ALA 94 94 94 N 13 12.74 1.90 113.70 126.44 A A A CA CB CG TRP TRP TRP 59 59 59 N 13 -9.16 1.30 126.60 117.44 A A A CB CG CD2 TRP TRP TRP 59 59 59 N 13 -10.78 1.40 110.10 99.32 A A A N CA CB ALA ALA ALA 94 94 94 N 15 -3.98 0.60 121.00 117.02 A A A CB CG CD2 TYR TYR TYR 74 74 74 N 15 4.25 0.60 121.00 125.25 A A A CB CG CD1 TYR TYR TYR 74 74 74 N 16 -10.51 1.50 110.10 99.59 A A A CB CA C ALA ALA ALA 94 94 94 N 17 -11.61 1.90 110.20 98.59 A A A CB CA C LEU LEU LEU 93 93 93 N 19 -11.72 1.90 110.20 98.48 A A A CB CA C LEU LEU LEU 81 81 81 N 1 A ILE 60 -147.50 -61.03 1 A TYR 74 84.80 -24.22 1 A LEU 88 -127.94 -166.98 1 A LYS 91 136.23 126.35 1 A ILE 92 82.30 22.12 1 A LEU 115 -100.30 -72.11 2 A ILE 60 -154.49 -60.91 2 A ALA 69 172.32 -45.86 2 A TYR 74 91.00 -36.97 2 A ARG 90 120.25 -33.51 2 A LYS 91 -178.01 127.99 2 A ILE 92 79.79 76.08 2 A LEU 93 177.35 -35.04 2 A LEU 115 -71.61 -77.24 2 A VAL 117 81.07 40.74 3 A ALA 61 71.46 -13.70 3 A TYR 74 85.09 -27.13 3 A ILE 86 -99.42 -64.86 3 A ASP 89 -139.94 -141.91 3 A ARG 90 76.79 -179.20 4 A ILE 60 -152.39 -63.18 4 A TYR 74 84.00 -28.66 4 A ILE 86 -100.50 -62.85 4 A GLU 87 32.04 71.67 4 A ARG 90 101.69 -24.03 4 A LYS 91 -175.52 118.87 4 A ILE 92 78.46 81.81 4 A LEU 93 176.13 -36.08 4 A VAL 98 -91.07 -63.73 4 A GLN 116 71.00 51.51 5 A ILE 60 -148.49 44.89 5 A TYR 74 96.16 -39.51 5 A ILE 86 -106.10 -65.41 5 A ARG 90 171.81 -38.26 5 A LYS 91 169.08 131.92 5 A ILE 92 70.18 78.04 5 A LEU 93 169.54 -34.07 5 A LEU 115 -103.80 -76.94 6 A ILE 60 -160.05 -63.85 6 A TYR 74 87.07 -21.48 6 A ILE 86 -105.85 -70.88 6 A ARG 90 89.96 -27.51 6 A LYS 91 -178.57 118.67 6 A ILE 92 79.50 82.41 6 A LEU 93 167.80 -32.92 6 A GLN 116 71.16 50.71 7 A ILE 60 -147.57 -64.19 7 A TYR 74 83.43 -25.57 7 A ASP 89 174.33 2.57 7 A ARG 90 -95.74 39.34 7 A LYS 91 112.57 131.89 7 A ILE 92 86.88 12.96 7 A LEU 115 -102.76 -75.85 8 A ILE 60 -141.50 -60.38 8 A ARG 68 -86.88 31.71 8 A TYR 74 82.12 -22.20 8 A ILE 86 -98.09 -71.48 8 A ARG 90 107.89 -26.77 8 A LYS 91 177.52 132.07 8 A ILE 92 85.53 14.92 9 A ILE 60 -137.52 -58.90 9 A ALA 69 175.91 -49.61 9 A TYR 74 84.76 -26.63 9 A LEU 88 -124.13 -166.70 9 A ASP 89 48.99 164.56 9 A ARG 90 95.44 66.76 9 A LYS 91 43.73 73.61 9 A ILE 92 -149.60 -48.14 9 A VAL 111 -93.55 33.79 9 A LEU 115 -71.60 -81.53 10 A ILE 60 -131.07 -64.99 10 A TYR 74 84.66 -26.69 10 A ILE 86 -88.79 -72.88 10 A ASP 89 -149.46 -51.22 10 A LEU 93 -156.70 -36.99 11 A ILE 60 -161.39 -62.08 11 A TYR 74 81.15 -29.44 11 A GLU 87 58.22 80.01 11 A LEU 88 -121.05 -153.33 11 A ASP 89 25.25 90.88 11 A LYS 91 171.78 132.48 11 A ILE 92 85.22 24.38 11 A GLN 116 70.60 49.85 12 A ILE 60 -148.51 -62.09 12 A TYR 74 79.44 -28.81 12 A LYS 91 126.65 126.21 12 A ILE 92 81.18 82.45 12 A LEU 93 179.08 -35.84 13 A ILE 60 -138.26 -69.27 13 A TYR 74 83.08 -19.04 13 A ASP 89 161.99 131.51 13 A ARG 90 179.38 80.52 13 A LYS 91 76.11 61.35 13 A ILE 92 -152.63 -33.75 13 A ALA 94 -25.98 -47.12 14 A ILE 60 -141.56 -77.44 14 A TYR 74 83.10 -28.96 14 A ARG 90 94.70 53.81 14 A LYS 91 68.76 64.55 14 A ILE 92 -158.70 -47.09 14 A GLN 116 -157.86 -69.64 14 A VAL 117 -162.33 -26.73 15 A ILE 60 -147.47 -57.39 15 A ALA 69 -179.57 -47.98 15 A TYR 74 92.36 -22.87 15 A LEU 88 -126.94 -161.26 15 A LYS 91 165.74 137.99 15 A ILE 92 86.97 4.89 15 A VAL 98 -97.51 -62.73 15 A ASP 100 -119.44 75.44 15 A GLN 116 70.86 42.14 16 A ILE 60 -149.10 -74.40 16 A TYR 74 82.16 -26.83 16 A ILE 86 -98.23 -66.91 16 A LEU 88 -121.08 -127.72 16 A ASP 89 73.41 -173.96 16 A ARG 90 87.11 50.35 16 A LYS 91 70.16 65.68 16 A ILE 92 -159.38 -46.55 17 A ILE 60 -141.03 -86.63 17 A TYR 74 83.31 -15.01 17 A ARG 90 -125.77 -168.88 17 A GLN 116 71.48 36.87 18 A ILE 60 -160.04 -65.02 18 A TYR 74 82.54 -31.67 18 A ILE 86 -111.44 -71.37 18 A ARG 90 -148.19 -33.36 18 A LYS 91 177.16 135.81 18 A ILE 92 91.54 -3.19 19 A ILE 60 -150.22 -56.28 19 A TYR 74 85.56 -30.42 19 A ILE 86 -103.18 -69.43 19 A GLU 87 37.93 62.76 19 A ARG 90 163.55 -29.65 19 A LYS 91 -178.41 123.67 19 A ILE 92 76.18 82.89 19 A LEU 93 168.33 -33.64 20 A ILE 60 -159.17 -76.21 20 A ARG 68 -90.19 35.40 20 A TYR 74 81.38 -28.03 20 A GLU 87 22.46 76.65 20 A LEU 88 -126.70 -135.42 20 A ASP 89 70.10 96.44 20 A ARG 90 -160.62 58.69 20 A LYS 91 66.33 65.80 20 A ILE 92 -151.07 -53.18 50S RIBOSOMAL PROTEIN L20 Bacterial ribosomal protein L20 from Aquifex aeolicus 1 N N A ILE 60 A ILE 2 HELX_P A ARG 68 A ARG 10 1 1 9 A TYR 74 A TYR 16 HELX_P A GLY 85 A GLY 27 1 2 12 A LEU 93 A LEU 35 HELX_P A ASP 100 A ASP 42 1 3 8 A ASP 100 A ASP 42 HELX_P A LEU 115 A LEU 57 1 4 16 RIBOSOMAL PROTEIN RIBOSOMAL PROTEIN, RIBOSOME, PROTEIN SYNTHESIS, TRANSLATIONAL CONTROL, RRNA-BINDING RL20_AQUAE UNP 1 O67086 59 118 1GYZ 59 118 O67086 A 1 1 60 1 P 1